Pain control was achieved by TUF in 70.0 percent of 240 patients; 18 patients underwent cystectomy for intractable pain<\/p>\n<\/h3>\n
By Elana Gotkine HealthDay Reporter<\/b>
\n<\/b><\/p>\n
MONDAY, May 5, 2025 (HealthDay News) — For patients with interstitial cystitis (IC), transurethral fulguration (TUF) is effective for alleviating pelvic pain, according to a study published online April 3 in Neurourology and Urodynamics<\/em>.<\/p>\n Hyun Ju Jeong, from the Seoul National University College of Medicine in South Korea, and colleagues conducted a retrospective analysis of electronic medical records of patients with IC who visited outpatient clinics with pelvic pain. Cystoscopic surgery based on TUF for bladder ulcers was used to manage pain; intractable pelvic pain was treated with cystectomy.<\/p>\n Overall, 240 of 275 patients underwent initial cystoscopic surgery; the mean number of TUF procedures was 1.0 during a median follow-up of 21.0 months. The researchers found that 71 of the 240 patients (29.6 percent) did not require further surgical treatment, while 26.7 percent required a second TUF for recurrent pelvic pain, with a median recurrence interval of 12.0 months. Fifteen of the 64 patients who received a second TUF (23.4 percent) underwent a third TUF after a median of 12.0 months. Five of the 15 patients who received a third TUF underwent a fourth TUF due to pain recurrence. One patient received a seventh TUF. Pain control with TUF was achieved by 168 of the 240 patients (70.0 percent). Eighteen (7.5 percent) of the patients underwent cystectomy.<\/p>\n “Our study results showed that TUF\u2010based cystoscopic surgery is an effective basic treatment for pelvic pain management in patients with IC,” the authors write.<\/p>\n